GUILLERMO
RUIZ IRASTORZA
PROFESORADO TITULAR DE UNIVERSIDAD
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario La Paz (11)
2021
-
Pregnancy Control in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Part 1: Infertility, Ovarian Preservation and Preconception Assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Rheumatology (SER)
Reumatologia Clinica, Vol. 17, Núm. 2, pp. 61-66
-
Pregnancy control in Patients with Systemic Lupus Erythematosus/Antiphospholipid Syndrome. Part 3: Childbirth. Puerperium. Breastfeeding Contraception. Newborn
Reumatologia Clinica, Vol. 17, Núm. 4, pp. 183-186
-
Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 2: Pregnancy follow-up
Reumatologia Clinica, Vol. 17, Núm. 3, pp. 125-131
2016
-
Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399
-
Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 34, Núm. 3, pp. 466-472
2014
-
Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: A prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)
Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 275-284
2012
-
Diagnosis and treatment of Lupus nephritis: Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish society of internal medicine (SEMI) and the Spanish society of nephrology (S.E.N.)
Nefrologia, Vol. 32, Núm. SUPPL. 1, pp. 1-45
-
Diagnosis and treatment of lupus nephritis
Revista Clinica Espanola
-
Diagnóstico y tratamiento de la nefritis lúpica: El camino del consenso
Revista Clinica Espanola, Vol. 212, Núm. 3, pp. 155-156
2010
-
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases
Clinical and Experimental Rheumatology, Vol. 28, Núm. 4, pp. 468-476
1999
-
Morbidity and mortality in systemic lupus erythematosus during a 5-year period: A multicenter prospective study of 1,000 patients
Medicine, Vol. 78, Núm. 3, pp. 167-175